Financhill
Buy
63

LPA Quote, Financials, Valuation and Earnings

Last price:
$10.76
Seasonality move :
-5.06%
Day range:
$10.40 - $11.01
52-week range:
$5.59 - $525.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
1.72x
Volume:
16.1K
Avg. volume:
94.4K
1-year change:
1.6%
Market cap:
$374.8M
Revenue:
--
EPS (TTM):
--
Period Ending 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Revenue -- -- -- $25.6M $32M
Revenue Growth (YoY) -- -- -- -- 24.96%
 
Cost of Revenues -- -- -- $4.1M $5.4M
Gross Profit -- -- -- $21.5M $26.6M
Gross Profit Margin -- -- -- 84.03% 83.09%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $5.4M $4.6M
Other Inc / (Exp) -- -- -- $10.6M $3.1M
Operating Expenses -- -- -- $5.4M $4.9M
Operating Income -- -- -- $16.1M $21.7M
 
Net Interest Expenses -- -- -- $9.3M $11.1M
EBT. Incl. Unusual Items -- -- -- $17.4M $13.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $8.8M $2.2M
Net Income to Company -- -- -- $8.7M $11.4M
 
Minority Interest in Earnings -- -- -- -$4.5M -$3.4M
Net Income to Common Excl Extra Items -- -- -- $4.1M $8M
 
Basic EPS (Cont. Ops) -- -- -- $0.12 $0.23
Diluted EPS (Cont. Ops) -- -- -- $0.12 $0.23
Weighted Average Basic Share -- -- -- $34.7M $34.7M
Weighted Average Diluted Share -- -- -- $34.7M $34.7M
 
EBITDA -- -- -- $27.5M $25.7M
EBIT -- -- -- $27.2M $25.4M
 
Revenue (Reported) -- -- -- $25.6M $32M
Operating Income (Reported) -- -- -- $16.1M $21.7M
Operating Income (Adjusted) -- -- -- $27.2M $25.4M
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Revenue -- -- -- $8.3M $10.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- $1.3M $1.5M
Gross Profit -- -- -- $6.9M $8.7M
Gross Profit Margin -- -- -- 83.74% 85.23%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- $1.3M $2.5M
Other Inc / (Exp) -- -- -- $1.4M $6.5M
Operating Expenses -- -- -- $1.3M $2.5M
Operating Income -- -- -- $5.6M $6.2M
 
Net Interest Expenses -- -- -- $3.9M $5.5M
EBT. Incl. Unusual Items -- -- -- $3.2M $7.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- $3.1M $4.9M
Net Income to Company -- -- -- $14M $9.2M
 
Minority Interest in Earnings -- -- -- -$325.1K -$1M
Net Income to Common Excl Extra Items -- -- -- -$213.1K $1.4M
 
Basic EPS (Cont. Ops) -- -- -- -$0.01 $0.04
Diluted EPS (Cont. Ops) -- -- -- -$0.01 $0.04
Weighted Average Basic Share -- -- -- $34.7M $34.7M
Weighted Average Diluted Share -- -- -- $34.7M $34.7M
 
EBITDA -- -- -- $7.2M $12.9M
EBIT -- -- -- $7.2M $12.9M
 
Revenue (Reported) -- -- -- $8.3M $10.2M
Operating Income (Reported) -- -- -- $5.6M $6.2M
Operating Income (Adjusted) -- -- -- $7.2M $12.9M
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- $1.4M $1.4M
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- $3.9M $13.8M
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -$325.1K -$2.4M
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Revenue -- -- -- -- $10.2M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- $1.5M
Gross Profit -- -- -- -- $8.7M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- $2.5M
Other Inc / (Exp) -- -- -- -- $6.5M
Operating Expenses -- -- -- -- $2.5M
Operating Income -- -- -- -- $6.2M
 
Net Interest Expenses -- -- -- -- $5.5M
EBT. Incl. Unusual Items -- -- -- -- $7.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- $4.9M
Net Income to Company -- -- -- -- $9.2M
 
Minority Interest in Earnings -- -- -- -- -$1M
Net Income to Common Excl Extra Items -- -- -- -- $1.4M
 
Basic EPS (Cont. Ops) -- -- -- -- $0.04
Diluted EPS (Cont. Ops) -- -- -- -- $0.04
Weighted Average Basic Share -- -- -- -- $34.7M
Weighted Average Diluted Share -- -- -- -- $34.7M
 
EBITDA -- -- -- -- $12.9M
EBIT -- -- -- -- $12.9M
 
Revenue (Reported) -- -- -- -- $10.2M
Operating Income (Reported) -- -- -- -- $6.2M
Operating Income (Adjusted) -- -- -- -- $12.9M
Period Ending 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Cash and Equivalents -- -- $15.5M $13M $12.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- $4.4M $6.1M $3.1M
Other Current Assets -- -- $2.3M $1.2M $892.2K
Total Current Assets -- -- $23.9M $29.6M $33.3M
 
Property Plant And Equipment -- -- $799.3K $637.9K $558.1K
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- $11.1M $9.2M $7.7M
Total Assets -- -- $409.3M $477.8M $497.6M
 
Accounts Payable -- -- $11.3M $3.7M $1.9M
Accrued Expenses -- -- -- $3.6M $6.4M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- $102.5K $1.3M $2.5M
Total Current Liabilities -- -- $25.9M $37M $125.7M
 
Long-Term Debt -- -- $114.9M $165.2M $98.4M
Capital Leases -- -- -- -- --
Total Liabilities -- -- $170.9M $240.3M $263.6M
 
Common Stock -- -- $100 $168.1M $168.1M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- $214.7M $206.3M $200.8M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- $23.6M $31.2M $33.3M
Total Equity -- -- $238.3M $237.5M $234.1M
 
Total Liabilities and Equity -- -- $409.3M $477.8M $497.6M
Cash and Short Terms -- -- $15.5M $13M $12.5M
Total Debt -- -- -- $188.7M $209.3M
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Cash and Equivalents -- -- -- -- $11.7M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory -- -- -- -- --
Prepaid Expenses -- -- -- -- $1.8M
Other Current Assets -- -- -- -- $3M
Total Current Assets -- -- -- -- $46.5M
 
Property Plant And Equipment -- -- -- -- $367.6K
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets -- -- -- -- $6.2M
Total Assets -- -- -- -- $554.4M
 
Accounts Payable -- -- -- -- $9.8M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- $9M
Total Current Liabilities -- -- -- -- $31.7M
 
Long-Term Debt -- -- -- -- $224.1M
Capital Leases -- -- -- -- --
Total Liabilities -- -- -- -- $300.9M
 
Common Stock -- -- -- -- $168.1M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- $35.4M
Total Equity -- -- -- -- $253.5M
 
Total Liabilities and Equity -- -- -- -- $554.4M
Cash and Short Terms -- -- -- -- $11.7M
Total Debt -- -- -- -- $234.7M
Period Ending 2018-12-31 2019-12-31 2020-12-31 2021-12-31 2022-12-31
Net Income to Stockholders -- -- -- $8.7M $11.4M
Depreciation & Amoritzation -- -- -- $236.6K $228.5K
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -$5.2M $1.1M
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- $9.9M $19.6M
 
Capital Expenditures -- -- -- $48.4M $41.1M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$66.9M -$36.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- $78.6M $44.2M
Long-Term Debt Repaid -- -- -- -$12M -$13.5M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- $2M -$1.4M
Cash From Financing -- -- -- $59.3M $14.8M
 
Beginning Cash (CF) -- -- -- $15.5M $17.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- $2.3M -$2.1M
Ending Cash (CF) -- -- -- $17.4M $15M
 
Levered Free Cash Flow -- -- -- -$38.5M -$21.5M
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Net Income to Stockholders -- -- -- $14M $9.2M
Depreciation & Amoritzation -- -- -- $173.6K $124.1K
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- $17.8M $14.6M
 
Capital Expenditures -- -- -- $31.2M $20.5M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -$30.6M -$16.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- $34.7M $121.9M
Long-Term Debt Repaid -- -- -- -$10M -$102.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -$443.8K -$2.4M
Cash From Financing -- -- -- $13.9M -$1.5M
 
Beginning Cash (CF) -- -- -- $17.4M $15M
Foreign Exchange Rate Adjustment -- -- -- -$426.2K -$124.1K
Additions / Reductions -- -- -- $997K -$3.2M
Ending Cash (CF) -- -- -- $17.9M $11.7M
 
Levered Free Cash Flow -- -- -- -$13.4M -$5.9M
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- $31.2M $51.7M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --
Period Ending 2019-09-30 2020-09-30 2021-09-30 2022-09-30 2023-09-30
Net Income to Stockholders -- -- -- -- $9.2M
Depreciation & Amoritzation -- -- -- -- $124.1K
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- $14.6M
 
Capital Expenditures -- -- -- -- $20.5M
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- -$16.4M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- $121.9M
Long-Term Debt Repaid -- -- -- -- -$102.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- -$2.4M
Cash From Financing -- -- -- -- -$1.5M
 
Beginning Cash (CF) -- -- -- -- $15M
Foreign Exchange Rate Adjustment -- -- -- -- -$124.1K
Additions / Reductions -- -- -- -- -$3.2M
Ending Cash (CF) -- -- -- -- $11.7M
 
Levered Free Cash Flow -- -- -- -- -$5.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SCHD a Good ETF to Buy?
Is SCHD a Good ETF to Buy?

With around $65.7 billion in net assets, Schwab’s US Dividend…

Is NAIL a Good ETF to Buy?
Is NAIL a Good ETF to Buy?

If you’re thinking about buying the NAIL ETF, this article…

3 High Dividend Dow Jones Stocks
3 High Dividend Dow Jones Stocks

Thanks to surging stock prices over the past two years,…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
57
NARI alert for Jan 8

Inari Medical [NARI] is up 0.13% over the past day.

Buy
69
UNF alert for Jan 8

UniFirst [UNF] is up 4.89% over the past day.

Sell
31
APOG alert for Jan 8

Apogee Enterprises [APOG] is down 6.84% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock